BioSpace News Archive

Drug Development

Rgenix Treats First Patient in Phase 1 Trial of RGX-202

Rgenix, Inc. today announced it has treated the first patient in a Phase 1 a/b study of RGX-202.

October 31, 2018
·
3 min read
Business

Ocular Therapeutix™ To Report Third Quarter 2018 Financial Results

Ocular Therapeutix™, Inc. today announced that it will report third quarter ended September 30, 2018 financial results on Wednesday, November 7, 2018.

October 31, 2018
·
2 min read
Tilray, Inc. to Present at the 2018 Morgan Stanley Global Consumer and Retail Conference

Tilray, Inc. today announced that Brendan Kennedy, President and Chief Executive Officer, and Mark Castaneda, Chief Financial Officer, Secretary and Treasurer, will present at the Morgan Stanley Global Consumer and Retail Conference.

October 31, 2018
·
1 min read
Business

Naya Clinics: Reinventing therapy in Denver with a new location in Lo Do

Naya Clinics accelerates expansion plans in North America to meet increasing demand for Positive Existential Therapy™ (PET), founder Sam Nabil’s unique approach to psychotherapy.

October 31, 2018
·
1 min read
Biotech Bay

Magnet® Survey Finds Nurses Believe Technology-Guided Patient Turns will Improve Health Outcomes, Reduce Pressure Ulcers

Survey shows nurses believe technology like the Leaf Patient Monitoring System could help reduce pressure ulcers, a top target of hospital quality improvement initiatives

October 31, 2018
·
3 min read
Pharm Country

The Author Stan’s Story Of Struggle On The Vicious Cycle Of Worry And Fear

As the author of a book on managing fear, Stan struggled with fear, anxiety, and worry for over 20 years.

October 31, 2018
·
1 min read
Policy

Nutriband Inc. Receives ‘Intention to Grant’ Notice from European Patent Office for Abuse Deterrent Transdermal Technology Utilized in the Defent™ Abuse Deterrent Fentanyl Transdermal System

The patent relates to the company’s proprietary abuse deterrent transdermal technology, utilized in the Defent™ fentanyl transdermal system which is being developed at 4P Therapeutics to combat fentanyl overdose.

October 31, 2018
·
4 min read
FDA

Cerus Receives FDA Breakthrough Device Designation for Pathogen-Reduced Cryoprecipitate

The basis of the designation is improved treatment of massive hemorrhage, a life-threatening medical condition.

October 31, 2018
·
4 min read
Business

Gilead Sciences and Tango Therapeutics Announce Strategic Collaboration to Develop Next-Generation Targeted Immuno-Oncology Therapies

Global strategic collaboration to discover, develop and commercialize a pipeline of innovative targeted immuno-oncology treatments for patients with cancer.

October 31, 2018
·
4 min read
Capua BioServices Completes Expansion of GMP Manufacturing Capabilities

Capua BioServices, Europe’s largest, independent provider of high quality services in microbial contract development and manufacturing services for pharma and food industry, has announced the completion of the renovation of one of the recovery and purification plants, at its facility in Capua, Italy.

October 31, 2018
·
2 min read